CinRx Pharma, LLC - 06 Jan 2022 Form 3 Insider Report for CinCor Pharma, Inc.

Role: 10%+ Owner
Signature: CinRx Pharma, LLC, By /s/ Jonathan Isaacsohn, CEO
Issuer symbol: N/A
Transactions as of: 06 Jan 2022
Net transactions value: $0
Form type: 3
Filing time: 10 Jan 2022, 15:12:41 UTC
Next filing: 13 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CINC	Common Stock						2,407,573	06 Jan 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CINC	Series A Preferred Stock							06 Jan 2022	Common Stock	630,251		Direct	F1
holding	CINC	Series B Preferred Stock							06 Jan 2022	Common Stock	592,279		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series A Preferred Stock and Series B Preferred Stock will automatically convert into shares of Common Stock on a 3.4:1 basis immediately prior to the closing of the Issuer's initial public offering and have no expiration date.